Home › Amgen cholesterol drug meets goal of third late stage trial
 

Keywords :   


Amgen cholesterol drug meets goal of third late stage trial

2014-01-23 21:17:14| Biotech - Topix.net

A cholesterol fighter developed by Amgen Inc from a new class of medicines succeeded in significantly lowering levels of "bad" LDL cholesterol in a late stage trial in patients unable to tolerate statin drugs, the company said on Thursday.

Tags: late stage trial goal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
14.05P&G Unveils Plans to Feature Brands During the Olympic and Paralympic Games Paris 2024
14.05The LOccitane Group Appoints Evelyne LY-Wainer Managing Director Global Travel Retail
14.05Recovery resources available for Texas livestock producers
14.05About-Face and AF94 Appoint Francesca Raminella as New CEO
14.05An unraveled genetic mystery in Angus
14.05Is HPAI a risk to beef cattle?
14.05Fresh Partners with Juno Shen on Limited-Edition Kombucha Facial Treatment Essence
More »